Form 4: CHEMED Director Sells Shares Under Pre-Arranged Plan

CHEMED Corp. Director Patrick P. Grace sold 150 shares of common stock for $463.39 per share on September 9, 2025, under a Rule 10b5-1 plan.

Summary

• Patrick P. Grace, a Director of CHEMED Corp., reported a sale of company capital stock.
• The transaction involved the disposition of 150 shares.
• The shares were sold at a price of $463.39 per share.
• Following this transaction, Mr. Grace directly owns 3,397 shares of CHEMED Corp.
• The sale was executed on September 9, 2025.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sale of shares by a director, while under a Rule 10b5-1 plan, represents a reduction in insider ownership. However, the pre-arranged nature of the sale mitigates immediate negative sentiment, making it a neutral event in isolation.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, which suggests a pre-scheduled sale rather than an immediate reaction to new, material non-public information.

Negatives

• A director selling shares reduces their direct stake in the company, which could be perceived negatively by some investors.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sale of 150 shares of CHEMED Corp. capital stock by Director Patrick P. Grace to the open market.

Stakeholder Impact

• Shareholders may interpret the director's sale as a slight negative signal, though this is mitigated by the disclosure that the transaction was executed under a Rule 10b5-1 plan.

Key Dates

Recommendation

The sale of 150 shares by a director, while a reduction in insider holdings, was conducted under a Rule 10b5-1 plan. This indicates the transaction was pre-scheduled and not necessarily based on new, material non-public information. Such a transaction, in isolation, is generally not a strong enough signal to warrant a change in a fundamental investment recommendation unless it is part of a larger pattern of insider selling or combined with other significant news. Therefore, a 'hold' recommendation is appropriate, maintaining the current stance on the stock.

Keywords

CHEMED Corp, CHE, Form 4, Insider Sale, Director, Stock Transaction, Rule 10b5-1, Patrick P. Grace